Varicella-zoster vwirus (VZV) persists in human sensory ganglia. One of the hypotheses to explain the induction or the maintenance of VZV latency is that it could be promoted by the immune response itself. It is known that in the case of viruses which bud off the infected cell membrane, virus-specific antibodies can induce antigenic modulation, i.e., spatial redistribution of viral antigens and modulation of their synthesis. To determine whether antigenic modulation occurs during VZV infection in vitro and could possibly be involved in viral persistence, we have grown infected cells in the presence of anti-VZV antibodies either transiently or permanently. The distribution of immune complexes and viral proteins was then analyzed. In transient immunomodulation experiments, the distribution of one or more viral antigens was modified not only in the cytoplasmic membranes but also in the cytoplasm and nucleoplasm of infected cells. When infected cells were kept permanently in the presence of antibodies, the same pattern of redistribution of immune complexes was observed and the localization of internal viral glycoproteins was significantly modified. However, antibodies did not prevent the ytic effect of infection; they altered neither the infectious virus yield nor the Western immunoblot pattern of viral proteins, suggesting that immunomodulation is not the primary effector of viral persistence.
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Varicella-zoster virus (VZV) is a human herpesvirus which causes a primary infection in childhood, becomes latent in dorsal root ganglia, and can be reactivated many years later to produce shingles in adults (10) . Investigation of mechanisms by which viruses become persistent and remain latent in infected cells progresses along two paths: (i) searches for a viral gene that is directly or indirectly responsible for latency and (ii) identification of host factors that induce viral latency. In the latter case, the main factor of interest is the host immune system. It has been shown that both in vitro and in vivo, persistence of a virus which buds at the plasma membrane of infected cells can be induced by the presence of antiviral antibodies at the time of virus maturation (20) (21) (22) (23) . Antibody treatment can induce a redistribution of membrane antigens which are assembled in patches and then in caps, as has been well documented for enveloped viruses budding at the plasma membrane, such as measles virus (8, 9, 13, 18) , a retrovirus (19) , or influenza virus (24) . Studies of measles virus have demonstrated that the effect of antibodies on the viral replication cycle is not restricted to a mechanical hindrance of the budding process. In fact, antibodies modulate through an unknown mechanism the synthesis of the viral glycoproteins expressed on the cell surface before budding (5) (6) (7) 14) . Regulation of gene expression has also been described for a parvovir'us (1) and a coronavirus (3) . The phenomenon of specific regulation of * Corresponding author. gene expression by antibodies was first described for cellular structural proteins and called immunomodulation by Stackpole et al. (25) . Such an immunomodulating effect on viral gene transcription could lead to persistence (17) and could account, on a mdlecular basis, for the data obtained for the induction of persistence by antibody pressure.
At first sight, such a phenomenon may seem rather unlikely for viruses of the family Herpesviridae, since they are known to mature at the inner nuclear membrane and in cytoplasmic vesicles. However, viral glycoproteins are expressed on the plasma membrane during infection. These proteins do not participate in the assembly of the viral particle, but they are fully accessible and can thus be targets for antiviral antibodies. During latency, high anti-VZV antibody levels can be detected (2) The original strain of VZV used in this study was isolated by sterile aspiration of vesicular lesions of a patient with chicken pox. Restriction analysis of the purified DNA showed the typical pattern of VZV Ellen strain. Infection was propagated by cocultivation of MRC-5 cells with VZVinfected MRC-5 cells (ratio of 1 infected cell to 3 uninfected cells).
Human anti-VZV antibodies were prepared by ammonium sulfate precipitation of a non-convalescent-phase human plasma with high anti-VZV antibody activity (>12,800 in enzyme immunoassay) and dialysis at 4°C in phosphatebuffered saline (PBS). Anti-VZV rabbit hyperimmune serum was obtained by immunization with VZV purified from infected MRC-5 cells followed by three steps of absorption on uninfected cells to decrease reactivity against nonviral antigens. Monoclonal antibodies were either obtained from Biosoft (Paris, France) (215-84/101) or produced in our laboratory (VL1 and VL8). The molecular weights of the viral polypeptides recognized by these monoclonal antibodies are listed in Table 1 were applied on polyacrylamide gels (4% [wt/vol] (Fig. 1A) . Mock-infected cells were cultured and treated in the same way. The fate of antigenantibody complexes was monitored. When cultured infected cells were exposed to antibodies specific of their membrane constituents, the immune complexes formed either were internalized (15) or remained on the cell membrane (20) . When cells were fixed at various times after immunomodulation and then incubated with rabbit anti-human IgG antibodies coupled to peroxidase (Dako) ( beled anti-human Ig antibody. Such complexes were homogeneously distributed on the cell surface immediately after antibody treatment (Fig. 2A) . If cells were allowed to recover after treatment, immune complexes formed patches randomly scattered on the surface (Fig. 2B) and then gathered in a cap (Fig. 2C) . Endocytosis followed; no labeling was detected after paraformaldehyde fixation, whereas cytoplasmic labeling was observed after acetone fixation, after which there was almost complete clearance of complexes from the cells.
The effect of antibody treatment was significant when free antigenic sites were observed by immunoperoxidase labeling. The most striking observation was the profound modification of the localization of viral epitopes recognized by an anti-gpII monoclonal antibody after the transient treatment.
In untreated cells, an epitope with a nuclear and cytoplasmic distribution was observed (Fig. 3A) . This distribution became exclusively cytoplasmic when cells were cultured for 2 h in the presence of anti-VZV antibodies (Fig. 3B) . When antibodies were washed away, it took only 60 min for the epitope localization to become nuclear again (Fig. 3C ). This modification of viral epitope localization was confirmed with an anti-gpI monoclonal antibody.
However, viral protein expression was unchanged qualitatively and perhaps only slightly delayed by transient immunomodulation; the anti-gpII monoclonal antibodies revealed two major bands (49 and 39 kDa) in Western blot analysis of VZV-infected MRC-5 cells, even in untreated cells and cells transiently treated with human anti-VZV antibodies (Fig. 4) . In the same way, no modification of the expression of viral proteins recognized by rabbit anti-VZV hyperimmune serum has been detected.
These transient immunomodulation experiments indicated that under the conditions described, antibodies reacted with viral antigens on infected cells in such a manner that they could induce significant modifications in these cells. Permanent immunomodulation experiments could then be undertaken. Infected and mock-infected cells were cultured in the presence of human anti-VZV antibodies for various times and then fixed (Fig. 1B) . The effects of immunomodulation were studied by searching for immune complexes on the cell surface, modifications of localization and expression of viral polypeptides, and production of infectious virus. The same pattern of redistribution of immune complexes on the cell surface was observed, and modifications of the localization of internal viral glycoproteins occurred as in transient treatment. Expression of viral polypeptides after 48 h of culture in the presence of anti-VZV antibodies was qualitatively unmodified, as indicated by Western blotting analysis with 
